by Prakash Achaary | May 21, 2021 | Blog
3 Approaches for Quality Control in the Pharma Industry By Jim Newman and Ravi Kishore Kandula Regulatory document quality is of the utmost importance in the pharmaceutical, biotechnology, and medical device industries to ensure data accuracy...
by Prakash Achaary | Aug 18, 2020 | News
MMS Academy Partners with MPGI to Bring Pharmaceutical Industry Virtual Learning to Students Across India Uttar Pradesh, India (August 18, 2020) – MMS Holdings Inc. (MMS) – an award-winning, data-focused and technology-enabled CRO – announced today that Maharana...
by Don McLean | Apr 8, 2020 | Blog
Whitepaper: Six Changes that Pharmaceutical Companies Should Consider in Response to COVID-19 [Fill out the form below to access the whitepaper] In the wake of the global pandemic of COVID-19, also known and SARS-COV-2, regulators, health authorities, and lawmakers...
by Don McLean | Jun 27, 2019 | Blog
Pharmaceutical Industry News Roundup: June 2019 by Staff writer Each month, MMS shares key stories on the evolution of the pharmaceutical industry. Here is a selection of top stories to keep an eye on: FDA ‘open for business’ in considering real-world evidence,...
by Don McLean | Jun 13, 2019 | Blog
Developing Treatments for Rare Diseases – Reviewing Draft Guidance from the FDA by Amanda Beaster, PhD, Andrew Chervenak, PhD, Halina Chkourko Gusky, PhD, and Ingrid Hansen, MS New and updated regulatory guidances from the US Food and Drug Administration (FDA),...
